Off-the-Shelf cancer treatment trial seeks to tame tough tumors
NCT ID NCT06653023
Summary
This early-stage study is testing a new type of cancer treatment called universal CAR-T cells (REVO-UWD-03) for people with advanced liver or lung cancer. The goal is to see if this 'off-the-shelf' therapy, made from healthy donor cells, is safe and can help control these cancers. Researchers will first find the safest dose and then check if it shrinks tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi'an, Shaanxi, 710061, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Jiangsu Cancer Hospital
RECRUITINGNanjing, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.